Robert B. Clarke

20.6k citations

168 papers · 13.7k indexed · 3 hit papers · h-index 54

Impact in

Oncology top 0.2%
- Cancer Cells and Metastasis
- Cancer-related Molecular Pathways
- Cancer Risks and Factors
Cancer Research top 0.5%
- Cancer Genomics and Diagnostics
- Breast Cancer Treatment Studies

Papers in

Oncology 116
- Cancer Cells and Metastasis 85
- Cancer-related Molecular Pathways 22
- Cancer Risks and Factors 12
Cancer Research 39
- Breast Cancer Treatment Studies 20
- Cancer Genomics and Diagnostics 9

Co-authors: Anthony Howell Gillian Farnie Sarah Lewington Paul Sherliker Jonathan Emberson Nawab Qizilbash Gary Whitlock Rory Collins
Journals: Breast Cancer Research (25 papers)Oncotarget (11 papers)Journal of Mammary Gland Biology and Neoplasia (10 papers)Cancer Research (8 papers)British Journal of Cancer (5 papers)
Partner nations: United Kingdom United States Spain

In The Last Decade

Robert B. Clarke

166 papers receiving 13.4k citations

Hit Papers

align trajectories log scale

Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research 2014 · 1.2k citations

Peers

Countries citing papers authored by Robert B. Clarke

Since Specialization

Citations

This map shows the geographic impact of Robert B. Clarke's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert B. Clarke with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert B. Clarke more than expected).

Fields of papers citing papers by Robert B. Clarke

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Robert B. Clarke. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert B. Clarke. The network helps show where Robert B. Clarke may publish in the future.

Co-authors

The 25 scholars most cited alongside Robert B. Clarke, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Robert B. Clarke Line = papers co-authored together Robert B. Clarke links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	SUMOylation regulates the aggressiveness of breast cancer-associated fibroblasts Cellular Oncology ·罗友升, حمادي السايح, U. Malcangi, Ana Machuca, Olga M. Antón, Susan Sun Xiuzhi, José L. Luque-García, Robert B. Clarke, Sonia Castillo‐Lluva	2024	3
2	Imagine beyond: recent breakthroughs and next challenges in mammary gland biology and breast cancer research Journal of Mammary Gland Biology and Neoplasia ·Renée van Amerongen, Mohamed Bentires‐Alj, Antonius L. van Boxtel, Robert B. Clarke, Silvia Fré, Eva González‐Suárez, Richard Iggo, Martin Jechlinger, Jos Jonkers, Marja L. Mikkola, Zuzana Koledová, Thérese Sørlie, María dM Vivanco	2023	3
3	RAC1B function is essential for breast cancer stem cell maintenance and chemoresistance of breast tumor cells Oncogene ·Fuhui Chen, Siti Akmalia, David Novo, Çiğdem Selli, Denis Alférez, Yasuyuki Noda, Kyriaki Pavlou, Jingwei Zhang, Andrew H. Sims, Neil Humphreys, Antony Adamson, Andrew D. Campbell, Owen J. Sansom, Cathy Tournier, Robert B. Clarke, Keith Brennan, Charles Streuli, Ahmet Uçar	2023	8
4	Prevention Of Breast and Endometrial cancer using Total Diet Replacement (PROBE-TDR) trial: protocol for a randomised controlled trial BMJ Open ·Il Tae Kim, Michelle Harvie, G N Marsh, Suzanne Krizak, Katharine Sellers, Hannah Harrison, Yit Yoong Lim, Caroline A. Parkin, R L Thorndike, Basil Issa, Anthony Maxwell, Julie Wisely, John Belcher, Robert B. Clarke, Anthony Howell, Emma J. Crosbie, Sacha J. Howell	2022	1
5	Reciprocal priming between receptor tyrosine kinases at recycling endosomes orchestrates cellular signalling outputs The EMBO Journal ·Michael P. Smith, T. H. M., Jennifer Ferguson, Egor Zindy, Anne Frery, Alessio Caroselli, Natasha Innocent, Meunier Jean-roch, А. Оралкул, Daniela Quintero Baca, Juan José de la Vega, Stacey Warwood, David Knight, Robert B. Clarke, Chiara Francavilla	2021	14
6	FAK inhibition alone or in combination with adjuvant therapies reduces cancer stem cell activity npj Breast Cancer ·S Timbrell, Napoleón Vicente, Angela Cramer, M.S. Ganachari, David T. Weaver, Jonathan A. Pachter, A. Bancal, Robert B. Clarke, Gillian Farnie, Nigel Bundred	2021	22
7	Tailored Functionalized Magnetic Nanoparticles to Target Breast Cancer Cells Including Cancer Stem-Like Cells Cancers ·Ana Lázaro-Carrillo, Macarena Calero, Antonio Aires, Aitziber L. Cortajarena, Bruno M. Simões, Alfonso Latorre, Álvaro Somoza, Robert B. Clarke, Rodolfo Miranda, Ángeles Villanueva	2020	16
8	The Notch Pathway Promotes Osteosarcoma Progression through Activation of Ephrin Reverse Signaling Molecular Cancer Research ·Ling Yu, Kezhou Xia, Tian Gao, 章允杉浦, Zhengpei Zhang, Kweon-Ill Kim, Bruno M. Simões, Rachel Eyre, Zhengfu Fan, Weichun Guo, Robert B. Clarke	2019	31
9	Acquired Resistance of ER-Positive Breast Cancer to Endocrine Treatment Confers an Adaptive Sensitivity to TRAIL through Posttranslational Downregulation of c-FLIP Clinical Cancer Research ·健島村, Andreia Silva, Tim Robinson, Angélica Santiago-Gómez, Bruno M. Simões, Michael W. Becker, Iduna Fichtner, Ladislav Anděra, Ruppecht Matthaei, Christine M. Morris, Peter Barrett‐Lee, Fouad Alchami, Marco Piva, María dM Vivanco, Robert B. Clarke, Julia M.W. Gee, Richard Clarkson	2018	42
10	G Protein-Coupled Receptors at the Crossroad between Physiologic and Pathologic Angiogenesis: Old Paradigms and Emerging Concepts International Journal of Molecular Sciences ·Liu Yu-zhong, Federica Sotgia, Robert B. Clarke, Michael P. Lisanti, Marcello Maggiolini	2017	35
11	The seventh ENBDC workshop on methods in mammary gland development and cancer Breast Cancer Research ·Marina A. Glukhova, Nancy E. Hynes, María dM Vivanco, Renée van Amerongen, Robert B. Clarke, Mohamed Bentires‐Alj	2015	0
12	Targeting Treatment-Resistant Breast Cancer Stem Cells with FKBPL and Its Peptide Derivative, AD-01, via the CD44 Pathway Clinical Cancer Research ·Lana McClements, Anita Yakkundi, Angelos Papaspyropoulos, Hannah Harrison, Matthew P. Ablett, Puthen V. Jithesh, Hayley D. McKeen, R. Avery Bennett, 隆雄武藤, Adrien Kissenpfennig, Stuart McIntosh, Helen O. McCarthy, Eric O’Neill, Robert B. Clarke, Tracy Robson	2013	55
13	Combined Inhibition of ErbB1/2 and Notch Receptors Effectively Targets Breast Ductal Carcinoma In Situ (DCIS) Stem/Progenitor Cell Activity Regardless of ErbB2 Status PLoS ONE ·Gillian Farnie, 蔡媛媛, Robert B. Clarke, Nigel Bundred	2013	32
14	Contrasting Hypoxic Effects on Breast Cancer Stem Cell Hierarchy Is Dependent on ER-α Status Cancer Research ·Hannah Harrison, Lynsey Rogerson, Y. L. Chen, Keith Brennan, Robert B. Clarke, Göran Landberg	2012	50
15	Regulation of Breast Cancer Stem Cell Activity by Signaling through the Notch4 Receptor Cancer Research ·Hannah Harrison, Gillian Farnie, Sacha J. Howell, Rebecca E. Rock, Spyros Stylianou, Keith Brennan, Nigel Bundred, Robert B. Clarke	2010	427
16	Biomarkers of Dietary Energy Restriction in Women at Increased Risk of Breast Cancer Cancer Prevention Research ·Kai Ren Ong, Andrew H. Sims, Michelle Harvie, Mary Ann Chapman, Warwick B. Dunn, David Broadhurst, Royston Goodacre, Mary Wilson, Polaki Suman, Robert B. Clarke, Anthony Howell	2009	39
17	Targeting inhibitor of apoptosis proteins in combination with ErbB antagonists in breast cancer Breast Cancer Research ·Fiona Foster, Thomas W. Owens, Jolanta Tanianis-Hughes, Robert B. Clarke, Keith Brennan, Nigel Bundred, Charles Streuli	2009	67
18	Are Stem-Like Cells Responsible for Resistance to Therapy in Breast Cancer? Breast Disease ·Ciara O’Brien, Gillian Farnie, Sacha J. Howell, Robert B. Clarke	2008	10
19	Do early premalignant changes in normal breast epithelial cells predict cancer development? Breast Cancer Research ·Robert B. Clarke, Nigel Bundred	2004	2
20	Molecular prediction of progression of prostate cancer in conservatively managed patients. Urology ·М. А. Баклашова, Robert B. Clarke, Erik S. Anderson, Noel W. Clarke, Waliyuddin Mohamed Salleh	2001	3

About Robert B. Clarke

Robert B. Clarke is a scholar working on Oncology, Cancer Research, Genetics, Molecular Biology and Biotechnology, having authored 168 papers that have together received 13.7k indexed citations. Recurring topics across this work include Cancer Cells and Metastasis (85 papers), Estrogen and related hormone effects (29 papers), Cancer-related Molecular Pathways (22 papers), Breast Cancer Treatment Studies (20 papers), Wnt/β-catenin signaling in development and cancer (15 papers), Developmental Biology and Gene Regulation (14 papers), Cancer Risks and Factors (12 papers) and Cancer Genomics and Diagnostics (9 papers). The work is most often cited by research in Oncology (5.8k citations), Cancer Research (2.6k citations), Pharmacy (409 citations), Molecular Biology (5.6k citations) and Genetics (2.2k citations). Robert B. Clarke has collaborated with scholars based in United Kingdom, United States and Spain. Frequent co-authors include Anthony Howell, Gillian Farnie, Sarah Lewington, Paul Sherliker, Jonathan Emberson, Nawab Qizilbash, Gary Whitlock, Rory Collins, Jim Halsey and Keith Brennan. Their work appears in journals such as Breast Cancer Research, Oncotarget, Journal of Mammary Gland Biology and Neoplasia, Cancer Research and British Journal of Cancer.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact